[
    {
        "id_label": "AbbVie",
        "ticker": "ABBV",
        "country": [
            "United States"
        ],
        "industry": [
            "biotechnology",
            "pharmaceutical industry"
        ],
        "aliases": [
            "AbbVie Inc.",
            "ABBV"
        ],
        "products": [
            "medication",
            "medical treatment"
        ],
        "subsidiaries": [
            "AbbVie s.r.o.",
            "AbbVie GK",
            "AbbVie (Bahamas)",
            "AbbVie (Bermuda)",
            "AbbVie Deutschland GmbH & Co. KG",
            "AbbVie (Australia)"
        ],
        "owned_entities": [],
        "ceos": [
            "Richard A. Gonzalez (Start: 2013-01-01T00:00:00Z) (End: 2024-07-01T00:00:00Z)",
            "Robert A. Michael (Start: 2024-07-01T00:00:00Z)"
        ],
        "board_members": [
            "Robert A. Michael (Start: 2024-07-01T00:00:00Z)",
            "Becky Roberts (Start: 2018-05-04T00:00:00Z)",
            "Brett Hart (Start: 2016-05-06T00:00:00Z)",
            "Richard A. Gonzalez (Start: 2013-01-01T00:00:00Z)",
            "Robert Alpern (Start: 2013-01-01T00:00:00Z)",
            "Susan Quaggin (Start: 2023-10-11T00:00:00Z)",
            "Roxanne Austin (Start: 2013-01-01T00:00:00Z)",
            "Glenn Tilton (Start: 2013-01-01T00:00:00Z)",
            "Melody Meyer (Start: 2017-05-05T00:00:00Z)",
            "Rick Waddell (Start: 2012-11-29T00:00:00Z)",
            "Edward J. Rapp (Start: 2013-01-01T00:00:00Z)",
            "Willie Burnside (Start: 2013-01-01T00:00:00Z)",
            "Tom Freyman (Start: 2020-05-08T00:00:00Z)",
            "Jennifer L. Davis (Start: 2023-10-11T00:00:00Z)"
        ]
    }
]